Print the page
Increase font size
Answering Your Questions

Answering Your Questions

Davis Wilson

Posted November 23, 2024

Davis Wilson

Davis is on a mission to turn $100,000 into $1 million. Follow along with his journey and get the opportunity to follow along in your own portfolio for free by clicking here.


Let’s get to it.

How much does it cost to subscribe to The Million Mission to get the trade alert at the time you place a trade? – Maxima

This is a question I get a lot. There is no option to upgrade to a paid Million Mission subscription. As of now this is a free benefit for being a member of the Altucher Investment Network. We are exploring ways to get trades to you in a more timely fashion. Stay tuned.

You mentioned you're buying calls at the $165 strike ending in January. But you also mentioned you're buying calls as insurance against a spike in share price shortly after earnings this afternoon. My question is why would a call at a strike almost $20 above the current share price be considered insurance against a spike in price when they release earnings? – Dan

This is a really great question, Dan. Insurance is typically thought of as a hedge on downside risk. In the case of me trading NVDA to the upside, I bought a small call option position as “insurance” against the stock spiking higher and me getting left behind.

In short, I believe in the company and the current valuation to a degree where I want to always be allocated in some fashion to the stock. A larger position, however, I’ll wait for a more opportune time.

Will you be informing your followers on when to sell that option? – Joe

Yes. As of now I’m still holding my January $165 call option position.

Will you be sharing exact entry and exit prices and number of contracts instead of percentages? – Ted

I can do this going forward. Just note, as a free service, these trades will not be tracked on the Paradigm website. You’ll need to follow along closely for this information.

I appreciate your teaching emails. There is something I still don’t get from all the emails you have sent about P/E ratio. When do we buy and when do we sell the stock using your explanations? – Pedro

The “Stock Picking Secrets Made Simple” email I shared on Friday is useful for any publicly-traded stock. The decision to buy will depend solely on your investing time horizon.

If you’re a longer-term investor (with a time horizon over one year) I’d be comfortable buying the stocks I’ve talked about in The Million Mission now.

Because I’m on a mission to turn $100,000 into $1 million, however, I’m taking much more risk with my portfolio and waiting to place options trades that have higher potential upside.

At what point do you cut your losses if a trade doesn't go your way? – Paul

Great question. I’m buying stocks/options on high-quality companies when they’re out of favor for various reasons. If a position initially moves against me, it will depend whether there is any company-specific news causing the stock reaction. If not, likely I’ll look to add to my position.

I am receiving your Million Mission newsletter. You say it’s affiliated with Paradigm Press. Why can't I access it through Paradigm's website? – Sue

The Million Mission alerts are currently being posted on the Altucher Confidential website. A standalone Million Mission website is in the works!

AI’s Millionaire Factory

Posted July 25, 2025

By Chris Campbell

The wealth curve is steep—and Steve’s riding it in flip-flops. Here’s how to catch up.

Bitcoin’s Red Queen Reckoning

Posted July 24, 2025

By Chris Campbell

The Red Queen treadmill of Bitcoin mining is shifting the crypto industry. Here’s how to play it.

“Use AI or Get Fired!”

Posted July 23, 2025

By Chris Campbell

Norway didn’t adopt AI to be trendy. They did it because slow decision-making is now a liability—and speed, precision, and adaptability are the new alpha.

The Next OpenAI is Tokenized

Posted July 22, 2025

By James Altucher

Here’s why I’m buying TAO every month like it’s internet real estate in 1995.

Cavities, Cancer, and the Great Biotech Revolt

Posted July 21, 2025

By Chris Campbell

If the decision goes through tomorrow morning? This may be the moment biotech history splits in two: Before and After.

Erebor Rises: Peter Thiel’s Massive Crypto Bet

Posted July 18, 2025

By Chris Campbell

Thiel isn’t the type to chase hype. He’s the type who builds the railroads before anyone realizes there’s gold in the hills.